SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-008670
Filing Date
2023-05-09
Accepted
2023-05-09 07:42:14
Documents
91
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xoma-20230331x10q.htm   iXBRL 10-Q 1993297
2 EX-10.7 xoma-20230331xex10d7.htm EX-10.7 376243
3 EX-31.1 xoma-20230331xex31d1.htm EX-31.1 10609
4 EX-31.2 xoma-20230331xex31d2.htm EX-31.2 10611
5 EX-32.1 xoma-20230331xex32d1.htm EX-32.1 8719
  Complete submission text file 0001558370-23-008670.txt   9386508

Data Files

Seq Description Document Type Size
6 EX-101.SCH xoma-20230331.xsd EX-101.SCH 86847
7 EX-101.CAL xoma-20230331_cal.xml EX-101.CAL 48424
8 EX-101.DEF xoma-20230331_def.xml EX-101.DEF 415979
9 EX-101.LAB xoma-20230331_lab.xml EX-101.LAB 598729
10 EX-101.PRE xoma-20230331_pre.xml EX-101.PRE 564851
85 EXTRACTED XBRL INSTANCE DOCUMENT xoma-20230331x10q_htm.xml XML 1399438
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39801 | Film No.: 23900016
SIC: 2834 Pharmaceutical Preparations